3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
50
Prostatic Neoplasms
44
Multiple Myeloma
22
Neoplasm Metastasis
17
Osteoporosis
14
Pain
11
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Neoplasms, Plasma Cell
5
Lung Neoplasms
5
Bone Diseases, Metabolic
5
Fractures, Bone
4
Bone Diseases
4
Lymphoma
3
Carcinoma, Renal Cell
3
Bone Neoplasms
3
Spinal Cord Compression
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Kidney Neoplasms
2
Humoral Hypercalcemia Of Malignancy
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Renal Insufficiency
1
Recurrence
1
Pleural Effusion, Malignant
1
Interventions
Blood Specimen Collection
13
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
3
Pirinitramide
2
Morphine
2
Bevacizumab
2
ribociclib
1
lanreotide
1
jinfukang
1
eribulin
1
cabazitaxel
1
Zoledronic Acid
1
Vinorelbine
1
Trastuzumab
1
Thiotepa
1
Taxes
1
Stem Cell Transplantation
1
Standard of Care
1
Spinal Puncture
1
Sorafenib
1
Radiofrequency Ablation
1
Propofol
1
Pemetrexed
1
Octreotide
1
Letrozole
1
Lapatinib
1
Injections, Epidural
1
Injections
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplastic Cells, Circulating
×
Zoledronic Acid
×
Clear all
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts